Search research articles
Contact Us
Filters
Showing results (81-90 of 108) with videos related to
Page
of 11
Sort By:
Nature Communications
|
March 1, 2024
Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab
Baoqing Chen, Shiliang Liu, Yujia Zhu, et al.
The Lancet. Oncology
|
March 29, 2023
Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): a single-arm, phase 2 trial
Yujia Zhu, Jing Wen, Qiaoqiao Li, et al.
Nature Communications
|
June 30, 2021
Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial
Shiliang Liu, Liling Luo, Lei Zhao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 9, 2017
The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy
Mian Xi, Cai Xu, Zhongxing Liao, et al.
Annals of Surgical Oncology
|
March 24, 2018
Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma
Lucas Goense, Peter S N van Rossum, Mian Xi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 20, 2023
A Surrogate Endpoint for Overall Survival in Locally Advanced and Resectable Esophageal Squamous Cell Carcinoma: A Reanalysis of Data From the NEOCRTEC5010 Trial
Tiantian Gao, Yong Yang, Zewei Zhang, et al.
Cancer Research and Treatment
|
May 5, 2026
Concurrent Chemoradiotherapy with or without Induction Chemoimmunotherapy in Unresectable Esophageal Squamous Cell Carcinoma: A Multicenter Real-World Study
Biqi Chen, Peiying Cen, Qi Cheng, et al.
Journal of Cancer
|
April 4, 2017
TNM Staging Matched-pair Comparison of Surgery After Neoadjuvant Chemoradiotherapy, Surgery Alone and Definitive Chemoradiotherapy for Thoracic Esophageal Squamous Cell Carcinoma
ShiLiang Liu, Bo Qiu, GuangYu Luo, et al.
Frontiers in Oncology
|
November 16, 2020
Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis
Yang-Xun Pan, Yi-Zhen Fu, Dan-Dan Hu, et al.
Eclinicalmedicine
|
August 10, 2023
A phase II clinical trial of toripalimab combined with neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (NEOCRTEC1901)
Rui Chen, Qianwen Liu, Qiaoqiao Li, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 108) with videos related to
Sort By:
Page
of 11
Nature Communications
|
March 1, 2024
Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab
Baoqing Chen, Shiliang Liu, Yujia Zhu, et al.
The Lancet. Oncology
|
March 29, 2023
Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): a single-arm, phase 2 trial
Yujia Zhu, Jing Wen, Qiaoqiao Li, et al.
Nature Communications
|
June 30, 2021
Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial
Shiliang Liu, Liling Luo, Lei Zhao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 9, 2017
The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy
Mian Xi, Cai Xu, Zhongxing Liao, et al.
Annals of Surgical Oncology
|
March 24, 2018
Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma
Lucas Goense, Peter S N van Rossum, Mian Xi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 20, 2023
A Surrogate Endpoint for Overall Survival in Locally Advanced and Resectable Esophageal Squamous Cell Carcinoma: A Reanalysis of Data From the NEOCRTEC5010 Trial
Tiantian Gao, Yong Yang, Zewei Zhang, et al.
Cancer Research and Treatment
|
May 5, 2026
Concurrent Chemoradiotherapy with or without Induction Chemoimmunotherapy in Unresectable Esophageal Squamous Cell Carcinoma: A Multicenter Real-World Study
Biqi Chen, Peiying Cen, Qi Cheng, et al.
Journal of Cancer
|
April 4, 2017
TNM Staging Matched-pair Comparison of Surgery After Neoadjuvant Chemoradiotherapy, Surgery Alone and Definitive Chemoradiotherapy for Thoracic Esophageal Squamous Cell Carcinoma
ShiLiang Liu, Bo Qiu, GuangYu Luo, et al.
Frontiers in Oncology
|
November 16, 2020
Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis
Yang-Xun Pan, Yi-Zhen Fu, Dan-Dan Hu, et al.
Eclinicalmedicine
|
August 10, 2023
A phase II clinical trial of toripalimab combined with neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (NEOCRTEC1901)
Rui Chen, Qianwen Liu, Qiaoqiao Li, et al.
Page
of 11